Floatz logo

Therapeutic Asset Ratings

136 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Haloperidol
Schizophrenia
Centre Hospitalier St AnneP4BB (67)
Letrozole
Schizophrenia
Central South UniversityP4BB (67)
Aripiprazole Lauroxil
Schizophrenia
University of MiamiP4BB (66)
Lorazepam
Schizophrenia
Temple UniversityP4BB (66)
Modafinil
Schizophrenia
University of MinnesotaP4BB (66)
MT-5199
Schizophrenia
Neurocrine BiosciencesP4BB (66)
Oxytocin
Schizophrenia
Charite University, Berlin, GermanyP4BB (66)
Varenicline Tartrate
Schizophrenia
University of California, San DiegoP4BB (66)
Risperidone Ism®
Schizophrenia
Rovi Pharmaceuticals LaboratoriesP3BB (66)
SERINE D-FORM
Schizophrenia
University of MinnesotaP3BB (66)
Iclepertin
Schizophrenia
Boehringer IngelheimP3BB (65)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Schizophrenia
Dr. Inge WinterP4BB (64)
Humulin R
Schizophrenia
Central Institute of Mental Health, MannheimP4BB (64)
Sra-333
Schizophrenia
Merck Sharp & Dohme LLCP4BB (64)
MELATONIN
Schizophrenia
Lahore General HospitalP4B (62)
Emraclidine
Schizophrenia
AbbVieP2B (61)
Agomelatine
Schizophrenia
Shanghai Mental Health CenterP4B (60)
Semaglutide
Schizophrenia
Ludwig-Maximilians - University of MunichP4B (60)
Topamax
Schizophrenia
All India Institute of Medical Sciences, BhubaneswarP4B (60)
UMBELLATINE
Schizophrenia
Tianjin Anding HospitalP4B (60)
lb-102
Schizophrenia
LB Pharmaceuticals Inc.P3B (60)
Karxt
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb companyP3B (59)
tv-44749
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLCP3B (59)
hs-10380
Schizophrenia
Jiangsu Hansoh Pharmaceutical Co., Ltd.P2B (59)
Acetylsalicylic Acid
Schizophrenia
Hôpital le VinatierP3B (58)
Showing 26 to 50 of 136 assets
PreviousPage 2 of 6Next